Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Squamous Non-small Cell Lung Cancer × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 525 Neoplasms 449 Carcinoma, Non-Small-Cell Lung 392 Prostatic Neoplasms 346 Lung Neoplasms 256 Colorectal Neoplasms 249 Neoplasm Metastasis 207 Leukemia, Myeloid, Acute 199 Multiple Myeloma 194 Ovarian Neoplasms 175 Melanoma 173 Pancreatic Neoplasms 149 Squamous Cell Carcinoma of Head and Neck 127 Brain Neoplasms 124 Recurrence 119 Carcinoma, Hepatocellular 117 Lymphoma 111 Urinary Bladder Neoplasms 108 Glioblastoma 106 Triple Negative Breast Neoplasms 105 Uterine Cervical Neoplasms 104 Stomach Neoplasms 104 Glioma 104 Endometrial Neoplasms 104 Carcinoma, Renal Cell 101 Precursor Cell Lymphoblastic Leukemia-Lymphoma 100 Lymphoma, Non-Hodgkin 90 Hematologic Neoplasms 88 Leukemia, Lymphocytic, Chronic, B-Cell 86 Sarcoma 83

Interventions

pembrolizumab 1 Paclitaxel 1 Carboplatin 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07221474 2026-03-12

INTerpath-13

Merck Sharp & Dohme LLC

Phase 2 Recruiting

Squamous Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡